- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Ajanta Pharma Limited — Updates, 08-10-2025: General Updates
08-10-2025 | 12:17 pm
08-10-2025 | 12:17 pm
Ajanta Pharma reported strong FY25 financials: ₹4,648 Cr revenue & ₹920 Cr PAT. Operational highlights include 27% Scope 1&2 emissions reduction, 12.6 MW new solar capacity, and zero hazardous waste to landfill. R&D secured 5 ANDA approvals, strengthening its product pipeline. CSR investment was ₹20.43 Cr.
No comments yet. Be the first to comment!